Tagged with GI

Baker & McKenzie Belgium Today, B&M differentiates itself by what it calls its ‘fluency’ in the way you think, work and behave which enables you to navigate the legal complexities across practices and boarders with ease and allows you to bring the very best of your global expertise to your clients. Has this model…

Array   An in-depth viewpoint on the current taxation situation for pharmaceutical companies operating in Belgium today, looking at incentive programs and relative positioning in Europe. Mr Eynatten, can you please provide our readers with an overview of the value added services that Deloitte offers to the life sciences industry in…

Array   Donald Niesten and Omer Saka discuss the current dynamics of the healthcare and pharmaceutical sectors in Belgium, the challenges of entering the market and the issue of effective communication with stakeholders, as well as offering opinions on the merits of ‘clusterization’.  Deloitte is certainly renowned for its strong network…

Lonza - Belgium Mr Pasini, before becoming site director of the Verviers plant you were acting as the Head of Investor Relations for Lonza. Can you provide us with an overview of your background and outline to what extent your previous role helped to prepare you to become Site Director of the Verviers…

Ferring - Belgium This August marks your sixth year at the helm of the Belgian affiliate of Ferring, what would you say best explains your loyalty to the company? One element that appeals to me about Ferring is that it offers a perfect compromise between entrepreneurial spirit and multinational scope which I believe…

P&G Singapore Innovation Center (SgIC) Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more consumers, particularly in emerging markets; Singapore is very central to that. From Singapore we can reach 2/3 of the world’s population within a 6…

UCB - Belgium UCB was founded in 1928 by Mr Emmanuel Janssen in Belgium, what spirit would you say its founder left behind and what core values unique to the company were you asked to perpetuate? Having been with the company for the past five years, it quickly became clear to me that…

Life Technologies Corporation The merger with Invitrogen-Applied Biosystems in 2008 was a big milestone for the company. As one of the leaders of this integration, can you please explain how this merger helped transform Life Technologies into the company it is today? The merger had an impact both internally and externally. Regarding the…

Life Technologies Corporation In the past two years Life Technologies has been investing in Singapore— last year you opened a regional distribution center in Singapore’s Tuas Biomedical Park and this June you established a Global Instrument Center of Excellence. What are the aims of both and how will they fit into the global…

Mylan - Belgium The generics market in Belgium doesn’t seem to be at the level it deserves to be. Considering that Mylan controls about 14% of the local generics market share, how would you assess the authorities and physicians attitude towards the generic drugs in Belgium? In Belgium, generic drugs are not being…

Sanofi - Belgium Mr Hendrickx, considering that you have been with Sanofi for over a decade, what would you describe as the single most important change in Sanofi’s business model? In essence, it is the diversification of Sanofi into a wide range of business activities. In the past, Sanofi was very successful at…

Hoya Surgical Optics Please give us an overview of HOYA Surgical Optics and its operations. HOYA Surgical Optics is a global manufacturer of intraocular lenses (IOLs) — the artificial lens that is put in the eye during cataract surgery when the natural lens clouds over with age and needs to be surgically removed.…